Metformin suppresses intestinal polyp growth in ApcMin/+ mice. - Wikidata - wikimedia - TriplyDB

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

http://www.wikidata.org/entity/Q46357678

about

Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Fundamentals of cancer metabolism Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers Cellular and molecular mechanisms of metformin: an overview Targeting mitochondria metabolism for cancer therapy Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis The effect of environmental chemicals on the tumor microenvironment Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications Do metformin a real anticarcinogen? A critical reappraisal of experimental data.Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis Cancer biology in diabetes.Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation Understanding the benefit of metformin use in cancer treatment.The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy.Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.Metformin and cancer.Metformin for aging and cancer prevention.Effects of metformin on retinoblastoma growth in vitro and in vivo.The complexities of obesity and diabetes with the development and progression of pancreatic cancer.Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy Inhibitory effect of metformin therapy on the incidence of colorectal advanced adenomas in patients with diabetes.A weighty problem: metabolic perturbations and the obesity-cancer link.The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes.Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial Combined use of vitamin D3 and metformin exhibits synergistic chemopreventive effects on colorectal neoplasia in rats and mice The insulin receptor: a new target for cancer therapy.Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse.Metformin for cancer and aging prevention: is it a time to make the long story short?Repurposing old drugs to chemoprevention: the case of metformin.Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice Obesity, energy balance, and cancer: new opportunities for prevention Anti-angiogenic Effects of Metformin, an AMPK Activator, on Human Umbilical Vein Endothelial Cells and on Granulation Tissue in Rat Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.

P2860

Q26741846-BFE84C33-16E1-40E6-A2EF-44E7308F02C3 Q26744062-72E6A2D9-D2DE-4FA5-8B7E-A947D2481EC7 Q26765139-D3C6D3FA-7B44-4F2F-9AEA-DB88F300AC3B Q26774577-FD3A4EA2-C20D-465A-B9DB-94009DCE11FD Q27013561-03DD579B-E945-4F1E-B6E2-CED40D9CA114 Q27027219-871334A4-E4F7-47BC-BD61-2601BED857BD Q28072501-95F7C844-B414-49E7-A49F-16EB6C1F3BD9 Q28085138-7DFC6694-9165-4A11-B159-D6B0FF0F2700 Q28539523-F3AF6029-5DA4-4265-8EAB-C1DDB73B9589 Q30239808-A5B1A456-5384-4F94-8803-444FD8A62F63 Q30863461-ACA2B2F8-081D-4EAE-99CA-084FD335642D Q33597162-8892652B-E875-4332-AF92-ABB14C66B2E2 Q33608038-A03FBEB8-96F9-4786-9AA3-DFFB7068CD17 Q33817206-81FB78D2-D13F-488D-BB68-376E9692B136 Q33864199-96B79257-548B-4F19-8218-8FE8EF7ED290 Q33893799-6AD60612-6428-4167-B3CB-8931FD94FBE4 Q33926391-E094D054-8AAD-4890-BED0-3EAA3247F1FD Q34104019-55F91C31-CF6B-4948-9A4E-EBF4B3116784 Q34159241-AF195F9E-EDC5-4360-B406-5CC2306CC434 Q34424886-06BCCE9F-D2FF-46BB-80EC-9330A12B49E9 Q34432841-BC1BEFFC-44B5-4EB9-A25C-E5573493A9E8 Q34669361-8D49759E-2B4E-404D-BB1E-04D988195C8C Q34887704-E9CB2160-A0B3-4C7B-AE3F-2CB214E32DF9 Q34998627-DBFBEA4A-3735-4962-9699-F91239597923 Q35104958-2F7184C5-CA08-4DB9-A627-5D0A02E05967 Q35368220-8204EBF1-F54F-44A9-9B89-A5B720DF22F4 Q35554181-1DE8DF15-9A82-4B49-B36D-FECA89E35A4D Q35689545-02A662A1-EDA3-4B0E-A5D9-3F97ABA75815 Q35854068-3E17534A-10D1-4E6E-A2F0-A81225E732D9 Q35963205-D5B321DA-A59D-4F5E-8A6F-A3D88EBCD858 Q35967148-833F3F58-9902-4160-BA23-886F6F752658 Q35972002-2B63C0C8-59B2-4089-B1DE-89D579B67E06 Q36026661-5F45A656-EEC1-49DD-92F4-B4C5B9D0405B Q36028206-629060C8-C4DC-4496-8D3B-EE1E0A7E1DA0 Q36545393-E6FD7FE3-A95F-4CB7-AE5C-5206FFC653EE Q36679911-93FB59B1-E739-4222-9346-DBA407CDE78D Q36786996-9889A07C-F459-4FF4-9A5F-D87A0BEA1F92 Q36810924-AA23878D-525A-4E79-9B4C-AA786825DC6D Q36821921-9A64AD3A-DCC9-45C8-956E-F745664A2F52 Q36901902-967D78A2-34C9-4CA7-AC94-3AE68A55AC05

P2860

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

http://www.wikidata.org/entity/Q46357678

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

@en

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

@nl

type

label

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

@en

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

@nl

prefLabel

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

@en

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

@nl

P1433

Q46357678-7E785F52-3816-49A6-9AD1-E97F811F3CB3

P1476

Q46357678-5D336A95-3AD3-4058-B7C8-93B42839C514

P2093

Q46357678-3B3DE0D9-BC69-48EF-9871-95320F4137A9

Q46357678-4783B664-9220-48AF-A772-A077DDBABC21

Q46357678-4A984C17-2CA9-43DD-A65A-5742041997DD

Q46357678-7EAE2109-1D92-4A7B-96ED-56D481EFAB39

Q46357678-A1E36121-B538-4CFB-8B9C-01932C1C0440

Q46357678-A5FBAF00-7D5B-4A14-95CD-44772FCB000E

Q46357678-A944F08B-16AB-4D27-9DAD-796205BFC404

Q46357678-B41BAF74-6683-47B7-8E2B-C58F9192B75D

Q46357678-C3E6F02F-04D3-43B0-A22B-786843D76095

Q46357678-D517E7A5-F77A-43F2-AE65-B9378F1B6D2B

P2860

Q46357678-0BDA57D8-783A-4CDF-BD15-6767EF4E3DEC

Q46357678-0DC8B079-3F22-45DB-8F66-0BD5DBEFB7A7

Q46357678-20663528-A8BD-4D7D-85BD-CD841CB8FBD7

Q46357678-282C434B-AC2B-4C90-AEFA-27689A4380F4

Q46357678-2A032BE0-CEE3-4080-A0A5-06BD734839F4

Q46357678-2A828979-2A0F-4F83-8F3D-A9D93621AC63

Q46357678-34F7A0E0-CAF2-4350-8D4F-9347F85D18CD

Q46357678-3B13D158-9426-466F-94F7-3C1165492EC2

Q46357678-45968577-4A50-405E-8B27-370EF467FE60

Q46357678-4E9FD1D6-FF8B-4D29-A837-EF18DF0F3319

P304

Q46357678-74BBC4F1-9584-4016-9A44-DB51D526DA2A

P31

Q46357678-68DEDE96-ECBE-4553-8D07-D98DF226F286

P356

Q46357678-994EECA4-9ABB-4421-ADD7-3243204B19D6

P433

Q46357678-8D59D27F-D3C1-42B2-8486-B51C587C9460

P478

Q46357678-DB51A8F2-A5E3-4A91-9DD0-F32474AB9EFB

P577

Q46357678-90CD7F2A-BD06-4FB5-B43F-A884599A14EE

P5875

Q46357678-F7C3F1F9-E8EC-47C9-A0D2-C62F24D9586F

P698

Q46357678-717078B8-56E4-4AA1-91E5-FFBFED24586E

P921

Q46357678-BB111D37-69D2-4BF9-BCB3-A18A803D1DDE

P356

J.1349-7006.2008.00933.X

P1433

P1476

Metformin suppresses intestinal polyp growth in ApcMin/+ mice.

@en

P2093

Atsushi Nakajima

http://www.w3.org/2001/XMLSchema#string

Ayako Tomimoto

http://www.w3.org/2001/XMLSchema#string

Hirokazu Takahashi

http://www.w3.org/2001/XMLSchema#string

Hiroki Endo

http://www.w3.org/2001/XMLSchema#string

Hitoshi Nakagama

http://www.w3.org/2001/XMLSchema#string

Koichiro Wada

http://www.w3.org/2001/XMLSchema#string

Kunihiro Hosono

http://www.w3.org/2001/XMLSchema#string

Michiko Sugiyama

http://www.w3.org/2001/XMLSchema#string

Noriko Nakajima

http://www.w3.org/2001/XMLSchema#string

Toshio Fujisawa

http://www.w3.org/2001/XMLSchema#string

P2860

The blooming of the French lilac

Role of AMP-activated protein kinase in mechanism of metformin action

Identification of c-MYC as a target of the APC pathway

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene

Cancer statistics, 2004

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

The expanding TOR signaling network.

P304

2136-2141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2008.00933.X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23268752

http://www.w3.org/2001/XMLSchema#string

P698

18803638

http://www.w3.org/2001/XMLSchema#string

P921